BACKGROUND: Solutions for Wellness (SfW) is an educational 3-month program concerning nutrition and exercise for persons with psychiatric disorders on psychotropic medication, who have weight problems. This observational study assessed the impact of SfW on subjective well-being, weight and waist circumference (WC). METHODS: Data was collected at 49 psychiatric clinics. Where the SfW program was offered patients could enter the intervention group; where not, the control group. Subjective well-being was measured by the Subjective Well-being under Neuroleptics scale (SWN), at baseline, at the end of SfW participation, and at a follow-up 6 months after baseline. Demographic, disease and treatment data was also collected. RESULTS: 314 patients enrolled in the SfW group, 59 in the control group. 54% of the patients had schizophrenia, 67% received atypical antipsychotics, 56% were female. They averaged 41 +/- 12.06 years and had a BMI of 31.4 +/- 6.35. There were significant differences at baseline between groups for weight, SWN total score and other factors. Stepwise logistic models controlling for baseline covariates yielded an adjusted non-significant association between SfW program participation and response in subjective well-being (SWN increase). However, statistically significant associations were found between program participation and weight-response (weight loss or gain < 1 kg) OR = 2; 95% CI [1.1; 3.7] and between program participation and WC-response (WC decrease or increase < 2 cm) OR = 5; 95% CI [2.4; 10.3]), at 3 months after baseline. CONCLUSIONS: SfW program participation was associated with maintaining or decreasing weight and WC but not with improved subjective well-being as measured with the SWN scale.
BACKGROUND: Solutions for Wellness (SfW) is an educational 3-month program concerning nutrition and exercise for persons with psychiatric disorders on psychotropic medication, who have weight problems. This observational study assessed the impact of SfW on subjective well-being, weight and waist circumference (WC). METHODS: Data was collected at 49 psychiatric clinics. Where the SfW program was offered patients could enter the intervention group; where not, the control group. Subjective well-being was measured by the Subjective Well-being under Neuroleptics scale (SWN), at baseline, at the end of SfW participation, and at a follow-up 6 months after baseline. Demographic, disease and treatment data was also collected. RESULTS: 314 patients enrolled in the SfW group, 59 in the control group. 54% of the patients had schizophrenia, 67% received atypical antipsychotics, 56% were female. They averaged 41 +/- 12.06 years and had a BMI of 31.4 +/- 6.35. There were significant differences at baseline between groups for weight, SWN total score and other factors. Stepwise logistic models controlling for baseline covariates yielded an adjusted non-significant association between SfW program participation and response in subjective well-being (SWN increase). However, statistically significant associations were found between program participation and weight-response (weight loss or gain < 1 kg) OR = 2; 95% CI [1.1; 3.7] and between program participation and WC-response (WC decrease or increase < 2 cm) OR = 5; 95% CI [2.4; 10.3]), at 3 months after baseline. CONCLUSIONS: SfW program participation was associated with maintaining or decreasing weight and WC but not with improved subjective well-being as measured with the SWN scale.
Authors: D Naber; S Moritz; M Lambert; F G Pajonk; R Holzbach; R Mass; B Andresen; F Rajonk Journal: Schizophr Res Date: 2001-05-30 Impact factor: 4.939
Authors: Kimberly H Littrell; Nicole M Hilligoss; Carol D Kirshner; Richard G Petty; Craig G Johnson Journal: J Nurs Scholarsh Date: 2003 Impact factor: 3.176
Authors: Maria Isabel Fernández-San-Martín; Luis Miguel Martín-López; Roser Masa-Font; Noemí Olona-Tabueña; Yuani Roman; Jaume Martin-Royo; Silvia Oller-Canet; Susana González-Tejón; Luisa San-Emeterio; Albert Barroso-Garcia; Lidia Viñas-Cabrera; Gemma Flores-Mateo Journal: Community Ment Health J Date: 2013-06-06
Authors: Cecília Attux; Larissa C Martini; Hélio Elkis; Sérgio Tamai; Andréa Freirias; Maria das Graças Miquelutti Camargo; Mário Dinis Mateus; Jair de Jesus Mari; André F Reis; Rodrigo A Bressan Journal: BMC Psychiatry Date: 2013-02-18 Impact factor: 3.630
Authors: Petter Andreas Ringen; John A Engh; Astrid B Birkenaes; Ingrid Dieset; Ole A Andreassen Journal: Front Psychiatry Date: 2014-09-26 Impact factor: 4.157